| Name | Title | Contact Details |
|---|---|---|
Wayne Kubick |
Chief Technology Officer | Profile |
ProPhase Labs (NASDAQ: PRPH) is a diversified medical science and technology company. The Company`s laboratory testing subsidiary, ProPhase Diagnostics, offers SARS-CoV-2 (COVID-19) and COVID-19 viral mutation PCR tests through both saliva and nasal swab methods at its CLIA certified laboratories. Critical to Covid testing, results are typically provided in under 24 hours. ProPhase Diagnostics also provides Respiratory Pathogen Panel (RPP) Molecular tests including Influenza A and B and others. ProPhase Labs researches, develops, manufactures, distributes, markets and sells OTC consumer healthcare products and dietary supplements, including dietary supplements under the TK Supplements® brand. The Company actively pursues strategic investments and acquisition opportunities for other companies, technologies and products.
Patterson Companies, Inc (Patterson) is a value-added distributor serving three markets: North American dental supply, United States companion-pet (dogs, cats and other common household pets) and equine veterinary supply, and the worldwide rehabilitation
Shiseido Cosmetics America Ltd. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Shiseido Cosmetics America Ltd. is based in New York, NY. You can find more information on Shiseido Cosmetics America Ltd. at www.sca.shiseido.com
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The Company is the worldwide technology leader in the field of proton therapy, the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room systems. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1200 people worldwide, IBA has installed systems across the world, from Europe and the US and to the emerging markets.
Amedisys is a leading home health and hospice care company focused on bringing home the continuum of care. We deliver personalized home health and hospice care to thousands of patients and their families, in the comfort of their own homes. Our care teams deliver personalized home health and hospice care to approximately 380,000 patients each year. Amedisys is a post-acute care partner to more than 2,233 hospitals and 61,900 physicians across the country. We provide the care that is best for our patients, whether that is home-based recovery and rehabilitation after an operation or injury, care focused on empowering them to manage a chronic disease, palliative care for those with a terminal illness, or hospice care at the end of life. Amedisys is a recognized innovator, being one of the first in the industry to equip its clinicians with point-of-care laptop technology and referring physicians with an internet portal that enables real-time coordination of patient care seamlessly. Amedisys also has the industry`s first-ever nationwide Care Transitions program, designed to reduce unnecessary hospital readmissions through patient and caregiver health coaching and care coordination, which starts in the hospital and continues throughout completion of the patient`s home health plan of care.